Western Europe remains at the forefront of evidence-based harm reduction and treatment interventions. The majority of the countries in the region have adopted a health-based strategy towards drug use (including decriminalisation of possession for personal use), and are moving towards more proportionate sentences for drug offences.
These studies provided estimates which were the best available at the time, but they were conceived as a starting point for further developments and hence also identified a number of ways in which they needed to be improved.
This report, prepared by the RAND Corporation for the House of Commons Select Committee on Science and Technology in the United Kingdom, presents the results of four case studies examining the evidence base for the classification of illegal drugs in the context of the 1971 Misuse of Drugs Act.
The third briefing paper from IDPC is a response to the call of the European Commission for civil society organisations to express their views on the Commission's Green Paper on the Role of Civil Society in Drugs Policy in the European Union.
The Home Office have published a research study called The economic and social costs of Class A drug use in England and Wales which provides a useful analyses of the wider costs of illegal drugs – the most thorough and recent such study available. The study, undertaken by York University, explains…
The proceedings of the 8th European Conference on Drugs and Infections Prevention in Prison, "Unlocking Potential: Making Prisons Safe for Everyone” organised by Cranstoun Drug Services on behalf of the European Network on Drugs and Infections Prevention in Prison, at Corinthia Grand Hotel,…
On 29 January 2004, an amendment to the drug laws came into effect in the UK that moved cannabis and its derivatives from Class B to Class C under the Misuse of Drugs Act 1971, the primary drug control legislation in the UK.
This handbook looks at the complex nature of the collaborative process from formation to the realisation, or otherwise, of agreed targets. It suggests ways of working around the ‘barriers’ that are likely to be encountered along the way. It could be relevant in the field of drug policy.
This research study provides estimates of the economic and social costs of Class A drug use in England and Wales for the year 2000. The methodology used to estimate costs will also enable future simulations of the relationship between various streams of government proactive and reactive expenditure.
This article provides some background information on drugs and drug usage in Portugal and trace the development of the changes in Portuguese drug policy and what the anticipated results of the changes will be.